DVBiologics to Deliver Lecture on Cryopreservation & Culture Expansion of Stem Cells

stem cell researchJoin DVBiologics on December 11-13, 2014 at The Venetian in Las Vegas on December 11-13, 2014 for the bi-annual A4M Conference. We kindly invite you to visit us at booths 5022 and 5020 to learn how regenerative medicine is the future of medicine and how it aims to treat diseases and degenerative disorders.

Rafael Gonzalez, PhD, the head of Research and Development Department at DaVinci Biosciences & DV Biologics, and Rehealth staff member, was invited to present at the American Academy of Anti-Aging Medicine Conference in Las Vegas on December 11, 2014 at 1:40 pm. With over 12 years of experience, Dr. Gonzalez has become a key opinion leader in the biomedical industry and has expansive knowledge on the behavior and expansion of stem cells and stem cell cryopreservation. His research includes stem cell applications for multiple diseases, degenerative disorders and research on the behavior of stem cell cultures and cell biology from several development stages.

The American Academy of Anti-Aging Medicine, also known as A4M, is a well-respected non-profit organization that is dedicated to the advancement of technology in detecting, preventing and treating aging related diseases and promoting research in the aging process.  A4M holds one of the largest conferences bi-annually on anti-aging, and regenerative and aesthetic medicine. This year, Dr. Gonzalez was once again afforded the opportunity to present as a keynote speaker on the cryopreservation of stem cells and on the culture expansion of stem cells. Below is an abstract of his presentation.

Cryopreservation & Culture Expansion of Stem Cells

Mesenchymal stem cells (MSCs) may be isolated from tissues such as adipose, bone marrow, umbilical cord tissue and blood. Following tissue processing, you will have the option of using your mixed cell product, such as stromal vascular fraction or purification of MSCs by expansion in culture. In 2006, there was a set of guidelines defining MSCs. One of the main characteristics is the ability to adhere to plastic. For cells to adhere to plastic, they require culture expanding MSCs and eventual cryopreservation. We will discuss methods of culture expansion and cryopreservation of MSCs. We will overview the use of the reagents necessary to start and expand MSCs. In addition, we will analyze methods of mesenchymal stem cell culture expansion and their implications in patient treatment. We will also discuss the importance and logistics of the cryopreservation process for your expanded MSCs.

Posted in DV Biologics News, Events | Tagged , , | Comments Off on DVBiologics to Deliver Lecture on Cryopreservation & Culture Expansion of Stem Cells

DV Biologics & The BioBox to exhibit at A4M

stem cell researchJoin DV Biologics and The BioBox on December 11-13, 2014 at The Venetian in Las Vegas on December 11-13, 2014 for the bi-annual A4M Conference. Please stop by booths 5022 and 5020 to learn more on how primary cells can help advance your drug discovery program. Also, learn the benefits of cryopreserving your stem cells today and how they can possibly help you in the future.

Posted in DV Biologics News, Events | Tagged , , | Comments Off on DV Biologics & The BioBox to exhibit at A4M

DVBiologics to Speak at RIO Grupo Stem Cell Conference

stem cell therapyDVBiologics Vicepresident of Research and Development, Rafael Gonzalez, Ph.D, has been invited to speak at the 17th annual “Curso Internacional de Actualización Clínico Radiológico” on January 23, 2015 at 1:15 p.m. located at the RIU Plaza Guadalajara Hotel in Mexico. Dr. Gonzalez will be lecturing on the advantages and breakthroughs in stem cell therapy.

 

The conference is organized by the RIO Grupo, whose mission is to bring together renowned local, national and international speakers in order to provide continuous training for their State Medical Guild. At this seminar, participants will learn about new diagnostic technologies, imagining study protocols for orthopedics and neurology and establish new networking relationships.

 

For more information on the conference and RIO Grupo, please visit http://www.grupo-rio.com/wp/.

Posted in DV Biologics News | Tagged | Comments Off on DVBiologics to Speak at RIO Grupo Stem Cell Conference

StemCells Regenerative Medicine Congress | Sept 15, 2014 | Boston, MA

Our VP of Research and Development, Rafael Gonzalez PhD., will be presenting at this year’s StemCells Regenerative Medicine Congress
in Boston, MA on September 15, 2014. He will be discussing umbilical cord lining stem cells as an off-the shelf product for osteoarthritis. To learn more about our clinical development programs in Regenerative Medicine please visit dvbiosciences.com

Posted in Events | Comments Off on StemCells Regenerative Medicine Congress | Sept 15, 2014 | Boston, MA

DVBiologics Team Publishes New Stem Cell Research Study

human primary cellsCOSTA MESA, CA. 19 May, 2014 – DaVinci Biosciences, LLC and its sister company DVBiologics announced today that their paper “Human Prenatal Intestine Cells as a Valuable Source of Stem Cells and Epithelial Cells; Phenotypic and Functional Characterization” has been accepted for publication in the peer-reviewed journal CELL & TISSUE TRANSPLANTATION & THERAPY.

 

With the current move by researchers and governments to reduce the use of animals in drug development and testing, scientist are looking for better and more cost effective ways to conduct their research for new and novel drugs for human disease. DVBiologics recognizes the need for new methods and models that will help get compounds from the bench top to clinical trials and has been continuously working to isolate and develop human primary cells for this purpose.

 

DaVinci Biosciences continues to research and develop cellular biology models that will promote the use of responsible science for the development and implementation of new approaches in the discovery of new regenerative medicine therapies. “It is a pleasure to work with DV Biologics in developing new cell based models for research and drug development. Our goal is to find more realistic models that may mimic the in vivo system,” says Dr. Rafael Gonzalez, VP of Research and Development of DVBiologics.  “It is our belief that these cell models will enable researchers to reduce the amount of animals used in drug discovery while getting faster results in the compounds safety and efficacy,” says Tony Delamaza, Vice President of Sales of DaVinci Biosciences, regarding the use of human primary cells.

 

About DaVinci Biosciences

DaVinci Biosciences is a leading global research and development company of human primary cells, cell derived products, and processes. DaVinci Biosciences distributes its cells and licenses its patents through its sister company DV Biologics.

 

About DV Biologics LLC

DV Biologics is a leading global supplier of human primary cells and cell-derived products.  DV Biologics manufactures the highest quality biological tools for use in academic institutions and pharmaceutical laboratories engaging in cell and drug based discovery and development. DV Biologics offers normal, human-derived primary cells and cell lines for research, genomic and proteomic biological tools, and a line of disease-specific primary cells and cell lines for the most accurate study of a particular disease profile.  All of DV Biologics’ products are validated under the strictest quality assurance and control parameters, providing customers with reliable, guaranteed quality products for reproducible results.

 

DaVinci Biosciences and DV Biologics are headquartered in Costa Mesa, California.

Posted in Announcement, DV Biologics News, Research | Tagged , | Comments Off on DVBiologics Team Publishes New Stem Cell Research Study

DVBiologics Scientist Speaks about Arthritis at A4M Conference

stem cell researchRafael Gonzalez, PhD, the head of Research and Development Department at DaVinci Biosciences and DVBiologics, was invited to present at the American Academy of Anti-Aging Medicine Conference in Orlando on May 17, 2014. With over 12 years of experience, Dr. Gonzalez has become a key opinion leader in the biomedical industry and has expansive knowledge on the behavior of stem cells and stem cell-based regenerative medicine in arthritis. His research includes clinical stem cell applications for multiple diseases,  degenerative disorders and research on the behavior of stem cell cultures and cell biology from several development stages.

The American Academy of Anti-Aging Medicine, also known as A4M, is a well respected non-profit organization that is dedicated to the advancement of technology in detecting, preventing and treating aging related diseases and promoting research in the aging process.  A4M holds one of the largest conferences bi-annually on anti-aging, and regenerative and aesthetic medicine. This year, Dr. Gonzalez was afforded  the opportunity to present as a key note speaker on the use of mesenchymal stem cells in the treatment of arthritis. Below is an abstract of his presentation.

Mesenchymal Stem Cells for the Treatment of Arthritis:  Translation From Clinical Research to Standard of Care in Clinical Practice

According to the World Health Organization (WHO), musculoskeletal disease is the most common cause of severe long-term pain and disability. The Centers for Disease Control (CDC), reports one in five adults in the United States  having doctor-diagnosed arthritis.  By 2030, an estimated 67 million Americans ages 18 years or older are projected to have doctor-diagnosed arthritis.  Current treatments for these conditions are limited in that they merely treat the symptoms of the condition, rather than addressing prevention or cure.  Additionally, many systemic remedies have undesirable gastrointestinal, renal, hepatic, and cardiac side effects.

Both osteoarthritis and rheumatoid arthritis both possess inflammatory and immunological involvement, which makes treatment confounding.  Mesenchymal stem cells are non-hematopoietic progenitor cells isolated from adult tissues that possess immunosuppression and anti-inflammatory effects.  Mesenchymal stem cells possess the ability to differentiate into osteoblasts (bone), adipocytes (fat), and chrondrocytes (cartilage).  Additionally, they aid in tissue regeneration in two ways.  First, mesenchymal cells secrete growth factors (transforming growth factor-beta, insulin-like growth factors, fibroblast growth factors, platelet-derived growth factors, and Wnts), which exert trophic effects on surrounding cells.  Second, they have the ability to coordinate tandem differentiation with differentiated and undifferentiated host cells.  These combined characteristics make mesenchymal stem cells an attractive therapeutic option for the treatment of arthritis.

The purpose of this presentation is to translate the research literature, protocols, and procedures into reproducible results that can be used in-office to effectively treat arthritic conditions.  A comprehensive review of the literature and research to date on the use of autologous adipose-derived and bone marrow-derived mesenchymal stem cells at the point of care utilizing the stromal vascular fraction for the treatment of arthritis will be provided.  The use of autologous mesenchymal culture expanded cells (bone marrow and adipose derived) in the treatment of osteoarthritis will be reviewed, as well as the use of allogeneic mesenchymal cells in osteoarthritis and rheumatoid arthritis treatments. Finally, the prospect of cryopreservation, cell banking, and culture expansion of mesenchymal stem cells will  be discussed.

Posted in DV Biologics News, Events | Tagged , | Comments Off on DVBiologics Scientist Speaks about Arthritis at A4M Conference

Join us at BIO | San Diego, CA | June 23-26

DV Biologics will be exhibiting at Bio International Convention 2014 in San Diego, CA on June 23rd-26th, 2014.  Stop by booth 6022 to learn how primary cells can help advance your drug discovery program.  Find out why companies worldwide are doing away with cell lines and animal models in favor of primary cells.

Posted in Uncategorized | Comments Off on Join us at BIO | San Diego, CA | June 23-26

DV Biologics to exhibit at the Annual Meeting of A4M in Orlando, FL on May 15-17, 2014

Dr Rafael Gonzalez our Vice President of Research& Development will be presenting on several topics. He will be presenting in the specialty workshops on Thursday, May 15th “The Importance of Standardizing and Characterizing you Stem Cell Product” and “Cryopreservation and Culture Expansion of Stem Cells” as part of the Stem Cell in Anti-aging: An Update workshop. On Saturday, May 17th he will be presenting in the general session, “Mesenchymal Stem Cells for the Treatment of Arthritis”.  To learn more please go to conference page.

Posted in Uncategorized | Comments Off on DV Biologics to exhibit at the Annual Meeting of A4M in Orlando, FL on May 15-17, 2014

25% off Muscle Progenitors and Chondrocytes

Limited Time Only: 25% off non-diseased muscle progenitor cells and chondrocytes

Researching sports injuries?  For a limited time, we are offering 25% off all muscle progenitor and chondrocyte products.  These products are ideal for researchers studying muscle and cartilage regeneration and tissue repair.

We are offering 25% off list prices for our Muscle Progenitor Cells and Chondrocytes

For more information about chondrocytes, check out our latest newsletter.

*Discounted items include cells, lysates, RNA, cDNA products. Ends on 6/30/14. Discounts are subject to change at any time without notice and cannot be combined with any other discount. Valid only on current stock.  Not valid for BioSource orders.

Posted in New Product, Promotions | Comments Off on 25% off Muscle Progenitors and Chondrocytes

Latest Newsletter: Human Chondrocytes

Read more about our Human Chondrocytes in our latest newsletter.

Posted in Newsletter | Comments Off on Latest Newsletter: Human Chondrocytes